Natus Medical Inc (NTUS) Return on Investment ROI from the first quarter of 2022 to first quarter of 2021 and for the year 2022, average high and low, overall ranking from Mar 31 2022 to Mar 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Natus Medical Inc  (NASDAQ: NTUS)


Natus Medical Inc's ROI from its first quarter of 2022 to the first quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Natus Medical Inc's ROI in the first quarter of 2022?
Natus Medical Inc achieved a return on average invested assets (ROI) of 2.79 % in its first quarter of 2022, which is below Natus Medical Inc's average return on investment, which stands at 3.83%.

ROI fell compared to the fourth quarter of 2021, despite the net income growth of 9.12% from the fourth quarter of 2021.

Within the Healthcare sector 207 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2021 from 2354 to 2375.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Investment Change TTM -1.12 % -4.82 % -7.43 % -7.25 % -4.85 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 455 450 457 454 445
Return On Investment (TTM) 2.79 % 2.92 % 3.71 % 0.39 % -2.31 %
NTUS's Overall Ranking # 2375 # 2354 # 2503 # 0 # 0
Seq. Investment Change TTM 0.57 % 0.63 % -0.41 % -1.9 % -3.19 %
Seq. Net Income Change TTM -3.74 % -20.79 % 852.26 % - -
Net Income (TTM) in Millions 13 13 17 2 -11

NTUS Company Profile >> Back to NTUS Roi Comparisons >> See Annual NTUS Return On Investment



Return On Investment NTUS's Ranking
Within: No.
Industry # 63
Sector # 208
Overall # 2375

Return On Investment Statistics
High Average Low
10.53 %
3.83 %
-9.05 %
(Sep. 30, 2015)   (Sep 30 2020)







Financial Statements
Natus Medical Inc's I. Quarter Investments $ 455 Millions NTUS's Balance sheet
Natus Medical Inc's I. Quarter Income $ 2 Millions Quarterly NTUS's Income Statement
NTUS's Income by Division See NTUS's Income by Division


NTUS Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 450 438 480 505 618
Y / Y Investment Growth 2.59 % -8.62 % -4.95 % -18.31 % 8.56 %
Net Income in Millions 13 -17 -16 -23 -20
Y / Y Net Income Growth - - - - -
Annual Return On Investment 2.93 % -3.79 % -3.27 % -4.54 % -3.28 %


Annual Roi Comment
In the fiscal year 2021 ROI improved to 2.93 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NTUS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NTUS's Competitors
Subscribers only: Roi for Natus Medical Inc's Suppliers
Subscribers only: Return On Investment for NTUS's Customers

Other Ratios
NTUS's Roa NTUS's Inventory Turnover Ratio NTUS's Growth Rates NTUS's Dividend Statistics
NTUS's Profitability Ratios NTUS's Asset Turnover Ratio NTUS's Dividend Growth
NTUS's Roe NTUS's Valuation Ratios NTUS's Financial Strength Ratios NTUS's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2022, within Healthcare Sector ROI
Teleflex Incorporated  7.67 %
Collegium Pharmaceutical Inc   7.62 %
Biogen Inc   7.49 %
Atea Pharmaceuticals Inc   7.49 %
Repligen Corp  7.45 %
Option Care Health Inc   7.41 %
Icu Medical Inc  7.15 %
Davita Inc   7.10 %
Electromed Inc   7.03 %
Charles River Laboratories International inc   6.90 %
Stryker Corp  6.66 %
Select Medical Holdings Corp  6.42 %
Zura Bio Limited  6.40 %
Envista Holdings Corporation  6.38 %
Docgo Inc   6.35 %
Global Cord Blood Corp  6.32 %
La Jolla Pharmaceutical Company  6.32 %
Ufp Technologies Inc   6.28 %
Pacific Health Care Organization Inc  6.26 %
Onemednet Corporation  6.23 %
Revvity Inc  6.13 %
Lakeland Industries Inc   6.11 %
Medtronic Plc  6.06 %
Dexcom Inc   6.06 %
Bionexus Gene Lab Corp   6.05 %
Dih Holding Us Inc   6.05 %
Tenet Healthcare Corp  6.00 %
National Vision Holdings Inc   5.73 %
Ensign Group Inc  5.69 %
Acadia Healthcare Company Inc   5.63 %

Date modified: 2026-09-26T07:17:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.